Opinion

Video

First-Line Treatment Strategies for HR+/HER2- Advanced Breast Cancer

Author(s):

Joyce O’Shaughnessy, MD,Laura Huppert, MD

Panelists discuss how to approach selecting first-line treatment options for hormone receptor–positive, HER2-negative advanced breast cancer by providing an overview of standard-of-care options and highlighting the primary considerations that guide treatment selection.

Video content above is prompted by the following:

  1. What is your approach to selecting first-line treatment options for hormone receptor–positive, HER2-negative advanced breast cancer? Please provide a high-level overview of standard-of-care treatment options in the first line.
  • What are primary considerations in selecting a first-line treatment?
Related Videos
Related Content